ARCHIVES

FDA, Genentech Agree On Framework for Avastin Hearing June 28-29

This article is from The Cancer Letter archive.

Vol. 37 No. 14 | April 8, 2011

Download PDF Visit The Full Archive

Related Articles

Interview: Burzynski Explains Why He Calls Treatment “Non-Toxic”

September 25, 1998

In Brief: FDA Names DeLap Directory Of Oncology

June 7, 1996

UT Health System’s Probe Finds Lapses at MD Anderson, CPRIT—But No Nepotism

June 15, 2012

National Coalition An Education Group, Chairman Says

May 3, 1985

Centers Agree To Broader Phase 1 Availability; Cool to Idea Of Distributing Group C Drugs

November 16, 1990

ONS Continue Growth, Associate Category Defeated Again

May 15, 1987